Sirolimus Protein-Bound Particles
This page contains brief information about sirolimus protein-bound particles and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
Use in Cancer
Sirolimus protein-bound particles are approved to treat adults with:
Sirolimus protein-bound particles are a form of sirolimus contained in nanoparticles (very tiny particles of protein). The drug is also called nanoparticle albumin-bound rapamycin. This form may work better than other forms of sirolimus and have fewer side effects.
Sirolimus protein-bound particles are also being studied in the treatment of other types of cancer.
More About Sirolimus Protein-Bound Particles
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
Clinical Trials Accepting Patients
Find Clinical Trials for Sirolimus Protein-bound Particles - Check for trials from NCI's list of cancer clinical trials now accepting patients.